CH695662A5 - Brivudin enthaltende pharmazeutische Zusammensetzung für die einmal tägliche Verabreichungn. - Google Patents

Brivudin enthaltende pharmazeutische Zusammensetzung für die einmal tägliche Verabreichungn. Download PDF

Info

Publication number
CH695662A5
CH695662A5 CH00987/01A CH9872001A CH695662A5 CH 695662 A5 CH695662 A5 CH 695662A5 CH 00987/01 A CH00987/01 A CH 00987/01A CH 9872001 A CH9872001 A CH 9872001A CH 695662 A5 CH695662 A5 CH 695662A5
Authority
CH
Switzerland
Prior art keywords
sep
brivudine
treatment
magnesium stearate
microcrystalline cellulose
Prior art date
Application number
CH00987/01A
Other languages
German (de)
English (en)
Inventor
Attilo Crea
Bettina Stubinski
Alessandro Casini
Original Assignee
Menarini Ricerche Spa
Berlin Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa, Berlin Chemie Ag filed Critical Menarini Ricerche Spa
Publication of CH695662A5 publication Critical patent/CH695662A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH00987/01A 2001-01-03 2001-05-29 Brivudin enthaltende pharmazeutische Zusammensetzung für die einmal tägliche Verabreichungn. CH695662A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (it) 2001-01-03 2001-01-03 Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera

Publications (1)

Publication Number Publication Date
CH695662A5 true CH695662A5 (de) 2006-07-31

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
CH00987/01A CH695662A5 (de) 2001-01-03 2001-05-29 Brivudin enthaltende pharmazeutische Zusammensetzung für die einmal tägliche Verabreichungn.

Country Status (20)

Country Link
AT (1) AT6141U1 (sk)
BE (1) BE1014522A5 (sk)
CH (1) CH695662A5 (sk)
CZ (1) CZ20012464A3 (sk)
DK (1) DK177084B1 (sk)
ES (1) ES2192456B1 (sk)
FI (1) FI20011446A (sk)
FR (1) FR2818907B1 (sk)
GB (1) GB2370771A (sk)
GR (1) GR1004012B (sk)
HR (1) HRPK20010345B3 (sk)
HU (1) HUP0102816A3 (sk)
IE (1) IE20010413A1 (sk)
IT (1) ITMI20010009A1 (sk)
NL (1) NL1018431C2 (sk)
PL (1) PL348480A1 (sk)
PT (1) PT102642B (sk)
SE (1) SE0102309L (sk)
SK (1) SK287043B6 (sk)
UA (1) UA76402C2 (sk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (es) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez Composicion farmacologica de uso topico para el tratamiento del herpes zoster.
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
DE69726255T2 (de) * 1996-01-19 2004-08-26 Glaxo Group Ltd., Greenford Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung

Also Published As

Publication number Publication date
HRP20010345A2 (en) 2003-08-31
NL1018431C2 (nl) 2002-07-05
PL348480A1 (en) 2002-07-15
FI20011446A (fi) 2002-07-04
SE0102309D0 (sv) 2001-06-28
PT102642B (pt) 2003-06-30
BE1014522A5 (fr) 2003-12-02
FI20011446A0 (fi) 2001-07-03
SE0102309L (sv) 2002-07-04
FR2818907B1 (fr) 2006-05-26
GR1004012B (el) 2002-11-01
PT102642A (pt) 2002-07-31
SK9572001A3 (en) 2003-03-04
SK287043B6 (sk) 2009-10-07
GB0110682D0 (en) 2001-06-20
GB2370771A (en) 2002-07-10
UA76402C2 (en) 2006-08-15
CZ20012464A3 (cs) 2002-08-14
FR2818907A1 (fr) 2002-07-05
ITMI20010009A0 (it) 2001-01-03
ES2192456B1 (es) 2005-02-01
HUP0102816A3 (en) 2005-01-28
GR20010100322A (el) 2002-10-08
HRPK20010345B3 (en) 2005-02-28
DK200101019A (da) 2002-07-04
ES2192456A1 (es) 2003-10-01
DK177084B1 (da) 2011-07-11
IE20010413A1 (en) 2003-04-16
HUP0102816A2 (en) 2002-10-28
ITMI20010009A1 (it) 2002-07-03
HU0102816D0 (en) 2001-09-28
AT6141U1 (de) 2003-05-26

Similar Documents

Publication Publication Date Title
DE69922964T2 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE69632034T2 (de) Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison
DE69310065T2 (de) Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
DE69400799T2 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE60115870T3 (de) Niedrig dosierte entecavir-formulierung und deren verwendung
DE60017281T2 (de) Nomegestrolacetat und östrogen enthaltende Hormonzusammensetzung und ihre Verwendung
EP1140082A1 (de) Kombination von cerivastatin und fibraten
DE602004005734T2 (de) Pharmazeutische zusammensetzung mit kontrollierter freisetzung und verfahren zu ihrer herstellung
CH695662A5 (de) Brivudin enthaltende pharmazeutische Zusammensetzung für die einmal tägliche Verabreichungn.
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
EP2374461B1 (de) Piroxicam zur prohylaktischen und therapeutischen Behandlung von Herpes-Infektionen
DE69925312T2 (de) Bupropion zur behandlung von viralen erkrankungen
WO2002007713A2 (de) Cilansetron enthaltende arzneimittel zur behandlung nicht-obstipativer männlicher ibs-patienten
EP0508511B1 (de) Erzeugnisse, enthaltend Verapamil und Trandolapril
DE10130128A1 (de) Brivudin enthaltende pharmazeutische Zusammensetzung für die einmal tägliche Verabreichung
DE3780702T2 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
DE2831728C2 (de) Arzneimittel zur Behandlung von Kopfschmerzen
EP2922552A1 (de) Verwendung und anwendungsregime einer pharmazeutischen zusammensetzung enthaltend levonorgestrel und einen cox-inhibitor zur bedarfsweisen ("on-demand") kontrazeption
EP0018550A2 (de) Mittel zur Behandlung von Muskelerkrankungen
DE3440140C2 (de) Verwendung von Thiamphenicol gegen die Gewöhnung an zentral wirkende Analgetika
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE10136615A1 (de) Schilddrüsentherapeutika
DE2823267A1 (de) Antihypertensive praeparate
DE3005029A1 (de) Antihypertensive pharmazeutische zubereitungen
DE10230272A1 (de) AT1-Rezeptorantagonisten zur Prävention von Folgeschlaganfällen

Legal Events

Date Code Title Description
PL Patent ceased